Download PDF
Klin Padiatr 2001; 213(S1): A22-A37
DOI: 10.1055/s-2001-17500
ORIGINALARBEIT

Georg Thieme Verlag Stuttgart · New York

Chemoprophylaxe bakterieller Infektionskrankheiten in der pädiatrischen Onkologie

Antimicrobial prophylaxis of bacterial infections in pediatric oncology patientsA.  Simon1 , G.  Fleischhack1 , G.  Marklein2 , J.  Ritter3
  • 1Abtl. für pädiatrische Hämatologie und Onkologie, Zentrum für Kinderheilkunde des Universitätsklinikums Bonn
  • 2Institut für Medizinische Mikrobiologie und Immunologie des Universitätsklinikums Bonn
  • 3Abtl. für pädiatrische Hämatologie und Onkologie, Klinik und Poliklinik für Kinderheilkunde der Universität Münster
Further Information

Publication History

Publication Date:
27 September 2001 (online)

Also available at
    Permissions and Reprints

Zusammenfassung.

Die Prävention bakterieller Infektionen ist von vorrangiger Bedeutung für die Morbidität und Letalität immunsupprimierter Patienten in der pädiatrischen Onkologie. Mit unterschiedlicher Evidenz können für die antibakterielle Chemoprophylaxe (ABCP) folgende Empfehlungen für pädiatrischonkologische Patienten ausgesprochen werden: Bei Implantation eines ventrikuloperitonealen Shunts (oder eines ventrikulären Reservoirs) wird eine perioperative antimikrobielle Prophylaxe empfohlen (IB). Zur Prävention systemischer Infektionen mit Streptococcus viridans sollten bei Patienten nach einer Knochenmarktransplantation eine Prophylaxe mit Penicillin erwogen werden, wenn es sich bei den Isolaten häufiger und schweren Infektionen überwiegend um penicillinsensible S. viridans handelt (IIIC). Pädiatrisch-onkologische Abteilungen müssen ein zeitnahes Monitoring der bakteriellen Resistenzsituation nach dem Infektionsschutzgesetz durchführen (IB, IV). Das Risiko der Besiedlung und Infektion mit resistenten Bakterienstämmen muss gegen den objektiven Nutzen der ABCP abgewogen werden (IB). Nicht empfohlen werden die perioperative antibiotische Prophylaxe bei Implantation eines getunnelten oder vollständig subkutan gelegenen zentralen Venenkatheters (IIID) und die antibakterielle Prophylaxe ZVK-assoziierter Infektionen durch den Zusatz von Vancomycin zur Katheterspüllösung (IB). Ebenso kann eine orale antibakterielle Prophylaxe mit nicht resorbierbaren Antibiotika auf der Grundlage der bislang vorliegenden Studien auch für pädiatrische Patienten mit lang anhaltender, hochgradiger Granulozytopenie nicht empfohlen werden (IC). Die bisher verfügbaren Studien sprechen gegen den Nutzen einer antibakteriellen Chemoprohylaxe mit Trimethoprim-Sulfamethoxazol für neutropenische Patienten in der pädiatrischen Onkologie (die PCP-Prophylaxe bleibt davon unberührt) (ID). Für oder gegen die antibakterielle Chemoprophylaxe mit (den in der Pädiatrie bislang nicht zugelassenen) Fluorchinolonen kann keine Empfehlung abgegeben werden (IIIC).AbkürzungenABCP Antibakterielle Chemoprophylaxe
ARA-C Cytosin Arabinosid
CPX Ciprofloxacin
ESBL Betalaktamase mit erweitertem Spektrum
FCH Fluorchinolone
HWK Harnwegskatheter
KMT Knochenmarktransplantation
KNS Koagulase-negative Staphylokokken
MR-KNS Methicillin-resistente koagulasenegative Staphylokokken
MRSA Methicillinresistenter Staphylococcus aureus
MRSE Methicillinresistenter Staphylococcus epidermidis
PCP Pneumocystis-carinii-Pneumonie
RKI Robert-Koch-Institut, Berlin
TMS Trimethoprim-Sulfamethoxazol (Cotrimoxazol)
SDD Selektive Darmdekontamination
VAN Vancomycin
VRE Vancomycinresistente Enterokokken
ZVK Zentraler Venenkatheter

Bacterial infections are still a major challenge in the treatment of pediatric cancer patients. Considering the evidence in the literature and published consensus opinions of experts the following strategies of antibacterial chemoprophylaxis (ABCP) in pediatric cancer patients can be recommended (or not recommended): Accompanying the implantation of a ventriculoperitoneal shunt (or a Rickham-reservoir) ABCP is recommended, until prospective controlled studies including pediatric cancer patients have investigated this issue. In bone marrow or stem cell transplant recipients, the prophylactic administration of penicillin should be considered, if severe oral mucositis is a common adverse event in cancer departments with high rates of penicillin-susceptible strains of Streptococcus viridans. Prospective surveillance of resistant bacterial pathogens should be an indispensable tool of quality control in pediatric oncology departments. The risk of infection with antimicrobial-resistant isolates should be balanced against the real benefit of antimicrobial prophylaxis in every instance. ABCP should neither be given during implantation nor during prolonged usage to prevent bacterial infection of a central venous access device (unproven efficacy and potential hazards of Vancomycin-resistant gram-positive infections). The oral administration of non-absorbable ABCP or Trimetoprim-Sufomethoxazole is not recommended for the prevention of bacterial infections (unproven efficacy) and no recommendation can be given for the oral ABCP with chinolones (lacking data, risk of antimicrobial resistance).

Schlüsselwörter

Antibakterielle Chemoprophylaxe - pädiatrische Onkologie

Key words

Antibacterial chemoprophylaxis - pediatric oncology

Literatur

  • 001 Aquino  V M, Pappo  A, Buchanan  G R, Tkaczewski  I, Mustafa  M M. The changing epidemiology of bacteremia in neutropenic children with cancer.  Pediatr Infect Dis J. 1995;;  14 140-143
    Google Scholar
  • 002 American Society of Gastrointestinal Endoscopy .Infection Control During Gastrointestinal Endoskopy. Guidelines for Clinical Application. Gastrointestinal Endoscopy 1999; 49: 836-841
    Google Scholar
  • 003 Balkundi  D R, Murray  D L, Patterson  M J, Gera  R, Scott-Emuakpor  A, Kulkarni  R. Penicillin-resistant Streptococcus mitis as a Cause of Septicemia with Meningitis in Febrile Neutropenic Children.  J Ped Hematol Oncol. 1997;;  19 82-85
    Google Scholar
  • 004 Barriga  F J, Varas  M, Potin  M, Sapunar  F, Rojo  H, Martinez  A, Capdeville  V, Becker  A, Vial  P A. Efficacy of a Vancomycin Solution to Prevent Bacteremia Associated With an Indwelling Central Venous Catheter in Neutropenic and Non-Neutropenic Cancer Patients.  Med Pediatr Oncol. 1997;;  28 196-200
    Google Scholar
  • 005 Berner  R, Schumacher  R F, Bartelt  S, Forster  J, Brandis  M. Predisposing Conditions and Pathogens in Bacteremia in Hospitalized Children.  Eur J Clin Microbiol Infect Dis. 1998a;;  17 337-340
    Google Scholar
  • 006 Berner  R, Sauter  S, Duffner  U, Brandis  M, Niemeyer  C M. Bakteriämie-Episoden bei pädiatrisch onkologischen Patienten, insbesondere durch Streptokokken der Viridans-Gruppe.  Klin Pädiatr. 1998b;;  210 256-260
    Google Scholar
  • 007 Berner  R. Antimikrobielle Therapie. In Lentze MJ, Schaub J, Schulte FJ, Spranger J (Hrsg). Pädiatrie - Grundlagen und Praxis. 1. Auflage. Springer-Verlag 2000; Kapitel 257,: S 1666
    Google Scholar
  • 008 Bochud  P Y, Eggiman  P, Calandra  T, Van Melle  G, Sgahfi  L, Francioli  P. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.  Clin Infect Dis. 1994;;  18 25-31
    Google Scholar
  • 009 Bock  S N, Lee  R E, Fisher  B, Rubin  J T, Schwartzentruber  D J, Wei  J P, Callender  D P, Yang  J C, Lotze  M T, Pizzo  P A. A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy.  J Clin Oncol. 1990;;  8 161-169
    Google Scholar
  • 010 Bodey  G P, Buckley  M, Sathe  Y S, Freireich  E J. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia.  Ann Intern Med. 1966;;  64 328-340
    Google Scholar
  • 011 Burgner  D, Siarakas  S, Eagles  G, McCarthy  A, Bradbury  R, Stevens  M. A prospective study of Clostridium difficile infection and colonization in pediatric oncology patients.  Pediatr Infect Dis J. 1997;;  16 1131-1134
    Google Scholar
  • 012 Cairo  M S, Spooner  S, Sowden  L, Bennetts  G A, Towne  B, Hodder  F. Long-Term Use of Indwelling Multipurpose Silastic Catheters in Pediatric Cancer Patients Treated With Aggressive Chemotherapy.  J Clin Oncol. 1986;;  4 784-788
    Google Scholar
  • 013 Castagnola  E, Lanino  E, Garaventa  A, Dini  G, Dall'Orso  S, Carrega  G, Viscoli  C. Prophylaxis of streptococcal bacteremia with oral penicillin V in children undergoing bone marrow transplantation.  Support Care Cancer. 1995;;  3 319-321
    Google Scholar
  • 014 Chanock  S J, Pizzo  P A. Infectious Complications of Patients Undergoing Therapy for Acute Leukemia: Current Status and Future Prospects.  Seminars in Oncology. 1997;;  24 132-140
    Google Scholar
  • 015 Chiou  C C, Wong  T T, Lin  H H, Hwang  B, Tang  R B, Wu  K G, Lee  B H. Fungal infection of ventriculoperitoneal shunts in children.  Clin Infect Dis. 1994;;  19 1049-1053
    Google Scholar
  • 016 Cruciani  M, Concia  E, Navarra  A. Prophylactic cotrimoxazole vs. norfloxacin in neutropenic children: prospective randomized study.  Infection. 1989;;  17 65-69
    Google Scholar
  • 017 Cruciani  M, Rampazzo  R, Malena  M, Lazzaroni  L, Todesschini  G, Messori  A, Concia  E. Prophylaxis with Fluoroquinolones for Bacterial Infections in Neutropenic Patients: A Meta-Analysis.  Clin Infect Dis. 1996;;  23 795-805
    Google Scholar
  • 018 Daghistani  D, Horn  M, Rodriguez  Z, Schoenike  S, Toledano  S. Prevention of Indwelling Central Venous Catheter Sepsis.  Med Ped Oncol. 1996;;  26 405-408
    Google Scholar
  • 019 Daschner  F. Emergence of Resistance during Selective Decontamination of the Digestive Tract (Editorial).  Eur J Clin Microbiol Infect Dis. 1992;;  11 1-3
    Google Scholar
  • 020 Dellinger  E P, Gross  P A, Barrett  T L, Krause  P J, Martone  W J, McGowan  J E Jr, Sweet  R L, Wenzel  R P. Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America.  Infect Control Hosp Epidemiol. 1994;;  15 182
    Google Scholar
  • 021 de Vries-Hospers  H G, Sleijfer  D T, Mulder  N H, van der Waaij  D, Neiweg  H O, van Saene  H K. Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.  Antimicrob Agents Chemother. 1981;;  19 813-20
    Google Scholar
  • 022 Ebner  W, Forster  D H, Rüden  H, Daschner  F. Evidenzbasierte Empfehlungen zur perioperativen Antibioticaprophylaxe.  Chirurg. 2000;;  71 912-917
    Google Scholar
  • 023 Ebner  W, Kropec-Hübner  A, Daschner  F D. Bacterial Resistance and Overgrowth due to Selective Decontamination of the Digestive Tract.  Eur J Clin Microbiol Infect Dis. 2000;;  19 243-247
    Google Scholar
  • 024 Elsner  H A, Sobottka  I, Feucht  H H, Harps  E, Haun  C, Mack  D, Ganschow  R, Laufs  R, Kaulfers  P M. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a German University Pediatric Hospital.  Int J Hyg Environ Health. 2000;;  203 147-152
    Google Scholar
  • 025 Elting  L S, Gerald  P B, Keefe  B H. Septicemia and shock syndrome due to viridans streptococci: A Case Control Study of Predisposing Factors.  Clin Infect Dis. 1992;;  14 1201-1207
    Google Scholar
  • 026 Engels  E A, Lau  J, Barza  M. Efficacy of Quinolone Prophylaxis in Neutropenic Cancer Patients: A Meta-Analysis.  J Clin Oncol. 1998;;  16 1179-1187
    Google Scholar
  • 027 Fanci  R, Leoni  F, Bosi  A, Guidi  S, Ciolli  S, Longo  G, Donnini  E, Rossi , Ferrini  P. Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs. ciprofloxacin plus amoxicillin.  J Chemother. 1993;;  5 119-123
    Google Scholar
  • 028 Ferrazzini  G, Klein  J, Sulh  H, Chung  D, Griesbrecht  E, Koren  G. Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia.  J Pediatr. 1990;;  117 823-826
    Google Scholar
  • 029 Ford  C D, Reilly  W, Wood  J, Classen  D C, Burke  J P. Oral antimicrobial prophylaxis in bone marrow transplant recipients: randomized trial of ciprofloxacin versus ciprofloxacin-vancomycin.  Antimicrob Agents Chemother. 1998;;  42 1402-1405
    Google Scholar
  • 030 Freifeld  A, Pizzo  P. Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients.  Pediatr Infect Dis J. 1997;;  16 140-146
    Google Scholar
  • 031 Gerding  D N, Johnson  S, Peterson  L R, Mulligan  M E, Silva  J. Clostridium Difficile-Associated Diarrhea and Colitis.  Infection Control Hosp Epidemiol. 1995;;  16 459-477
    Google Scholar
  • 032 Gerding  D N. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?.  Clin Infect Dis. 1997;;  25 Suppl 2 S206-210
    Google Scholar
  • 033 Gould  I M. A review of the role of antibiotic policies in the control of antibiotic resistance.  JAC. 1999;;  43 459-465
    Google Scholar
  • 034 Gomez-Martin  C, Sola  C, Hornedo  J, Perea  S, Lumbreras  C, Valenti  V, Arcediano  A, Rodriguez  M, Slaazar  R, Cortes-Funes  H, Hidalgo  M. Rifampicin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.  J Clin Oncol. 2000;;  18 2126-2134
    Google Scholar
  • 035 Graubner  U B, Boos  J, Creutzig  U, Dörffel  W, Lakomek  M, Niemeyer  C, Schrappe  M, Spaar  H J (Arbeitskreis Qualitätssicherung der GPOH) und Belohradsky BH. Die antiinfektiöse Prophylaxe in der pädiatrischen Onkologie.  Klin Pädiatr. 1999;;  211 347-352
    Google Scholar
  • 036 Green  M. Vancomycin Resistant Enterococci: Impact and Management in Pediatrics.  Adv Pediatr Infect Dis. 1997;;  13 257-277
    Google Scholar
  • 037 Guiot  H FL, Peters  W G, van den Broek  P J, van der Meer  J WM, Kramps  J A, Willemze  R, van Furth  R. Respiratory failure elicited by streptococcal septicemia in patients with cytosine arabinoside, and its prevention by penicillin.  Infection. 1990;;  18 131-137
    Google Scholar
  • 038 Guiot  H F, van der Meer  J W, van den Broek  P J, Willemze  R, van Furth  R. Prevention of viridans-group streptococcal septicemia in oncohematologic patients: a controlled comparative study on the effect of penicillin G and cotrimoxazole.  Ann Hematol. 1992;;  64 260-265
    Google Scholar
  • 039 Guiot  H F, van Furth  R. Selective decontamination in bone marrow transplant recipients.  Epidemiol Infect. 1992;;  109 349-360
    Google Scholar
  • 040 Guiot  H F, Corel  L J, Vossen  J M. Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders.  Eur J Clin Microbiol Infect Dis. 1994;;  13 645-650
    Google Scholar
  • 041 Habscheid  W, Bernhardt  C, Sold  M, Köhler  B, Marx  A, Kunz  E, Müller-Hermelink  H K. Atraumatische Clostridium septicum Infektion bei Granulozytopenie.  Deutsch med Wschr. 1991;;  116 1862-186641a Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized. Placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43: 1412 - 1416
    Google Scholar
  • 042 Henning  K J, Delencastre  H, Eagan  J, Boone  N, Brown  A, Chung  M, Wollner  N, Armstrong  D. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection.  Pediatr Infect Dis J. 1996;;  15 848-854
    Google Scholar
  • 043 Henrickson  K J, Shenep  J L, Flynn  P M, Pui  C H. Primary Cutaneous Bacillus cereus Infection in Neutropenic Children.  Lancet. 1989;;  I 601-603
    Google Scholar
  • 044 Hopkins  H A, Sinkowitz-Cchran  R L, Rudin  B A, Keyserling  H L, Jarvis  W R. Vancomycin Use in Pediatric Hematology-Oncology Patients.  Infect Control Hosp Epidemiol. 2000;;  21 28-50
    Google Scholar
  • 045 Horvatova  Z, Spanik  S, Sufliarsky  J, Mardiak  J, Pichna  P, Pichnova  E, Krajcik  S, Mraz  M, Chmelik  B, Dacok  J, Beresova  J, Krupova  I, Hrachova  A, Trupl  J, Kunova  A, Krcmery  V. Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive Bacteremia.  In J Antimicrob Agents. 1998;;  10 55-58
    Google Scholar
  • 046 Hospital Infection Control Practices Advisory Committee (HICPAC) .Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol (Internet http://www.cdc.gov) 1995; 16: 105-113
    Google Scholar
  • 047 Hughes  W T, Kuhn  S, Chaudary  S, Feldman  S, Verzosa  M, Aur  R JA, Pratt  C, George  S L. Successful Chemoprophylaxis for Pneumocystis Carinii Pneumonitis.  N Engl J Med. 1977;;  297 1419-1426
    Google Scholar
  • 048 Hughes  W T, Rivera  G K, Schell  M J, Thornton  D, Lott  L. Successful Intermittent Chemoprophylaxis for Pneumocystis Carinii Pneumonitis.  N Engl J Med. 1987;;  316 1627-1632
    Google Scholar
  • 049 Hughes  W T, Armstrong  D, Bodey  G P, Brown  A E, Edwards  J E, Feld  R, Pizzo  P, Rolston  K V, Shenep  J L, Young  L S. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America.  Clin Infect Dis. 1997;;  25 551-573
    Google Scholar
  • 050 Huovinen  P, Sundstrom  L, Swedberg  G, Skold  O. Trimethoprim and sulfonamide resistance.  Antimicrob Agents Chemother. 1995;;  39 279-289
    Google Scholar
  • 051 Imrie  K R, Prince  H M, Couture  F, Brandwein  J M, Keating  A. Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole.  Bone Marrow Transplant. 1995;;  15 267-270
    Google Scholar
  • 052 Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy .Antimicrobial prophylaxis in neurosurgery and after head injury. Lancet 1994; 344: 1547-1551
    Google Scholar
  • 053 Infektionsschutzgesetz .Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz - IfSG). Bundesgesetzblatt Teil 1 Nr. 3, Bonn; 25. Juli 2000:
    Google Scholar
  • 054 International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC) .Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin. JAMA 1994; 272: 1183-1189
    Google Scholar
  • 055 Johnson  D M, Jones  R N, Erwin  M E. Anti-streptococcal activity of SB-265 805 (LB 20 304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines.  Diagn Microbiol Infect Dis. 1999;;  33 87-91
    Google Scholar
  • 056 Jones  R N. Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia.  Clin Infect Dis. 1999;;  29 495-502
    Google Scholar
  • 057 Kaufhold  A, Behrendt  W, Krauss  T, van Saene  H. Selective decontamination of the digestive tract and methicillin-resistant Staphylococcus aureus.  Lancet. 1992;;  339 1411-1412
    Google Scholar
  • 058 Kern  W, Kurrle  E, Schmeiser  T. Streptococcal Bacteremia in adult patients with leukemia undergoing aggressive chemotherapy: a review of 55 cases.  Infection. 1990;;  18 138-145
    Google Scholar
  • 059 Kern  W V, Andriof  E, Oethinger  M, Kern  P, Hacker  J, Marre  R. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.  Antimicrob Agents Chemother. 1994;;  38 681-687
    Google Scholar
  • 060 Kern  W V, Hay  B, Kern  P, Marre  R, Arnold  R. A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.  Antimicrob Agents Chemother. 1994;;  38 465-472
    Google Scholar
  • 061 Kerr  K G. The prophylaxis of bacterial infections in neutropenic patients.  JAC. 1999;;  44 587-591
    Google Scholar
  • 062 Knippschild  M, Schmid  E N, Uppenkamp  M, Konig  E, Meusers  P, Brittinger  G, Hoffkes  H G. Alcalagines xylosoxidans subsp. xylosoxidans in neutropenic patients.  Oncology. 1996;;  53 258-262
    Google Scholar
  • 063 Kotilainen  P, Nikoskelainen  J, Huovinen  P. Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.  J Infect Dis. 1990;;  161 41-44
    Google Scholar
  • 064 Krcmery  V, Pichna  P, Oravcova  E. Stenotrophomonas maltophilia Bacteremia in cancer patients: report on 31 cases.  J Hosp Infect. 1996;;  34 75-77
    Google Scholar
  • 065 Krishnan  K, Krishnaswamy  G. Severe bactrim-induced neutropenia with reversal of CD4 +/CD8 + lymphocyte ratio: response to recombinant human granulocyte-colony stimulating factor (R-metHUG-CSF).  Clin Lab Haematol. 1998;;  20 187-188
    Google Scholar
  • 066 Krupova  Y, Novotny  J, Sabo  A, Mateicka  F, Krcmery  V. Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteriaemia during antimicrobial prophylaxis: a case-control study.  Int J Antimicrob Agents. 1998;;  10 313-316
    Google Scholar
  • 067 Lamy  T, Michelet  C, Dauriac  C, Grulois  I, Donio  P Y, Le Prise  P Y. Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective randomized trial among 59 patients.  Acta Haematol. 1993;;  90 109-113
    Google Scholar
  • 068 Langley  J M, LeBlanc  J C, Drake  J, Milner  R. Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis.  Clin Infect Dis. 1993;;  17 98-103
    Google Scholar
  • 069 Levy  I, Leibovici  L, Drucker  M, Samra  Z, Konisberger  S, Ashkenazi  S. A prospective study of gram-negative Bacteremia in children.  Pediatr Infect Dis. 1996;;  15 117-122
    Google Scholar
  • 070 Lew  M A, Kehoe  K, Ritz  J, Antman  K H, Nadler  L, Kalish  L A, Finberg  R. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.  J Clin Oncol. 1995;;  13 239-250
    Google Scholar
  • 071 Lowy  F D. Medical Progress: Staphylococcus aureus Infection. N Engl J Med 1998; 339: 520 - 53271a McGowan JE, Tenover FC. Control of Antimicrobial Resistance in The Health Care System.  Infect Dis Clin North Am. 1997;;  11 311
    Google Scholar
  • 072 McKee  R, Dunsmuir  R, Whitby  M, Garden  O J. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition?.  J Hosp Infect. 1985;;  6 419-425
    Google Scholar
  • 073 McWhinney  P HM, Kibbler  C C, Gillespie  S H, Patel  S, Morrison  D, Hoffbrand  A V, Prentice  H G. Stomatococcus mucilaginosus: An Emerging pathogen in neutropenic patients.  Clin Infect Dis. 1992;;  14 641-646
    Google Scholar
  • 074 Meirovich  J, Kitai-Cohen  Y, Keren  G, Fiendler  G, Rubinstein  E. Cerebrospinal fluid shunt infections in children.  Pediatr Infect Dis J. 1987;;  6 921-924
    Google Scholar
  • 075 Mooney  B R, Reeves  S A, Larson  E. Infection control and bone marrow transplantation.  Am J Infect Control. 1993;;  21 131-138
    Google Scholar
  • 076 Morrison  V A, Peterson  B A, Bloomfield  C D. Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia and type of malignancy.  Med Pediatr Oncol. 1990;;  18 209-216.
    Google Scholar
  • 077 Murray  B E. Vancomycin-Resistant Enterococcal Infections.  N Engl J Med. 2000;;  342 710-721
    Google Scholar
  • 078 Nourse  C, Murphy  H, Byrne  C, O'meara  A, Bretnach  F, Kaufmann  M, Clarke  A, Butler  K. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors of colonisation.  Eur J Pediatr. 1998;;  157 20-27
    Google Scholar
  • 079 Oethinger  M, Conrad  S, Kaifel  K, Cometta  A, Bille  J, Klotz  G, Glauser  M P, Marre  R, Kern  W V. Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers.  Antimicrob Agents Chemother. 1996;;  40 387-392
    Google Scholar
  • 080 Oethinger  M, Jellen-Ritter  A S, Conrad  S, Marre  R, Kern  W V. Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysis.  Infection. 1998;;  26 379-384
    Google Scholar
  • 081 Oppenheim  B A, Hartley  J W, Lee  W, Burnie  J P. Outbreak of coagulase-negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit.  BMJ. 1989;;  299 294-297
    Google Scholar
  • 082 Patrick  C C, Adair  J R, Warner  W C. Safety of ciprofloxacin as a prophylactic agent for prevention of Bacteremia infections in pediatric bone marrow transplantat (BMT) patients. [Abstract LM 17]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington D.C.; 1995;: 329
    Google Scholar
  • 083 Patrick  C C. Use of fluoroquinolones as prophylactic agents in patients with neutropenia.  Pediatr Infect Dis J. 1997;;  16 135-139
    Google Scholar
  • 084 Pearson  M L and The Hospital Infection Control Practices Advisory Committee. Guideline for prevention of intravascular device-related infections.  Am J Infect Control. (im Internet http://www.cdc.gov)  1996;;  24 262-293
    Google Scholar
  • 085 Pegues  D A, Carson  L A, Anderson  R L. Outbreak of Pseudomonas cepacia in oncology patients.  Clin Infect Dis. 1993;;  16 407-411
    Google Scholar
  • 086 Penzak  S R, Gubbins  P O, Stratton  S L, Anaissie  E J. Investigation of an outbreak of gram-negative Bacteremia among hematology-oncology outpatients.  Infect Contr Hosp Epidemiol. 2000;;  21 597-599
    Google Scholar
  • 087 Pignon  B, Thiriet  L, Aubert  D, Pennaforte  J L, Vilque  J P, Lartigue  B, Jolly  D, Bajolet-Laudinat  O, Etienne  J C. Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in postchemotherapy agranulocytic patients.  Nouv Rev Fr Haematol. 1990;;  32 249-252
    Google Scholar
  • 088 Pizzo  P A, Ladisch  S L, Gill  F A. Increasing incidence of gram positive sepsis in cancer patients.  Med Pediatr Oncol. 1978;;  5 241-244
    Google Scholar
  • 089 Pizzo  P A. The value of protective isolation in preventing nosocomial infections in high risk patients.  Am J Med. 1981;;  70 631-637
    Google Scholar
  • 090 Pizzo  P A, Schimpff  S C. Strategies for the Prevention of Infection in the Myelosuppressed or Immunosuppressed Cancer Patient.  Cancer Treat Rep. 1983;;  67 223-234
    Google Scholar
  • 091 Pizzo  P A. Considerations for the prevention of infectious complications in patients with cancer.  Rev Infect Dis. 1989;;  11 Suppl 7 S1551-1563
    Google Scholar
  • 092 Pizzo  E A, Rubin  M, Freifeld  A, Walsh  T J. The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies.  J Pediatr. 1991;;  119 679-694
    Google Scholar
  • 093 Perera  S, Hidalgo  M, Arcediano  A, Ramos  M, Gomez  C, Hornedo  J, Lumbreras  C, Folgueira  D, Cortes-Funes  H, Rodriguez-Noriega  A. Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high does chemotherapy and ciprofloxacin prophylaxis.  J Antimicrob Chemother. 1999;;  44 117-120
    Google Scholar
  • 094 Preclik  G, Grüne  S, Leser  H G, Lebherz  J, Heldwein  W, Machka  K, Holstege  A, Kern  W V. Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy.  BMJ. 1999;;  319 881-884
    Google Scholar
  • 095 Rackoff  W R, Weiman  M, Jakobowski  D, Hirschl  R, Stallings  V, Bilodeau  J, Danz  P, Bell  L, Lange  B. A randomised, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children.  J Pediatr. 1995;;  127 147-151
    Google Scholar
  • 096 Ranson  M R, Oppenheim  B A, Jackson  A, Kamthan  A G, Scarffe  J H. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients.  J Hosp Infect. 1990;;  15 95-102
    Google Scholar
  • 097 Richard  P, Amador del Valle  G, Moreau  P, Milpied  N, Felice  M P, Daeschler  T, Harousseau  J L, Richet  H. Viridans streptococci in patients with neutropenia.  Lancet. 1995;;  345 1607-1609
    Google Scholar
  • 098 Rieske  K, Handrick  W, Spencker  F B, Günther  E. Sepsis durch vergrünende Streptokokken bei Kindern mit malignen hämatologischen Erkrankungen.  Klin Pädiatr. 1997;;  209 364-372
    Google Scholar
  • 099 Ringden  O, Heimdahl  A, Lönnquist  B, Malmborg  A S, Wilczek  H. Decreased incidence of viridans streptococcal septicemia in allogenic bone marrow transplant recipients after the introduction of acyclovir.  Lancet. 1984;;  I 744
    Google Scholar
  • 100 Risi  G F, Tomascak  V. Prevention of infection in the immunocompromised host.  Am J Infect Control. 1998;;  26 594-605
    CrossrefPubMedGoogle Scholar
  • 101 Ritter  E, Thurm  V, Bauernfeind  A, Dorittke  C, Völpel  S, Finger  H. Nosocomial colonization and infection caused by multiresistant Enterobacter cloacae strains in a pediatric oncology ward.  Zbl Hyg. 1994;;  196 81-94
    PubMedGoogle Scholar
  • 102 Ritter  J. Pediatric Update: Acute Myeloid Leukaemias.  Eur J Cancer. 1998;;  34 862-872
    CrossrefPubMedGoogle Scholar
  • 103 Robert-Koch-Institut, Kommission für Krankenhaushygiene und Infektionsprävention .Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten-Staphylococcus aureus Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen. (1999) (Internet http://www.rki.de/GESUND/HYGIENE/HYGIENE.HTM). 
    Google Scholar
  • 104 Robert-Koch-Institut Berlin .Surveillance nosokomialer Infektionen sowie die Erfassung von Erregern mit speziellen Resistenzen und Multiresistenzen. § 6 Abs. 3 und § 23 Abs. 1 und 2 in Verbindung mit § 4 Abs. 2 Nr. 2 IfSG. Rechtliche Voraussetzungen und Umsetzungsempfehlungen. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2000; 43: 887-890
    Google Scholar
  • 105 Rodgers  G L, Mortensen  J E, Blecker-Shely  D, Fisher  M C, Long  S S. Two case reports and review of vascular catheter-associated Bacteremia caused by nontuberculous Mycobacterium species.  Pediatr Infect Dis J. 1996;;  15 260-264
    CrossrefPubMedGoogle Scholar
  • 106 Saavedra  J, Rodriguez  J N, Fernandez-Jurado  A, Vega  M D, Pascual  L, Prados  D. Necrotic soft-tissue lesion due to Corynebacterium urealyticum in a neutropenic child.  Clin Infect Dis. 1996;;  22 851-852
    PubMedGoogle Scholar
  • 107 Schaad  U B. Role of the new quinolones in pediatric practice.  Pediatr Infect Dis J. 1992;;  11 1043-1046
    PubMedGoogle Scholar
  • 108 Schaison  G, Baruchei  A, Ariet  G. Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized trial in neutropenic patients.  Br J Haematol. 1990;;  76: Suppl 2 24-26
    PubMedGoogle Scholar
  • 109 Schimpff  S C, Satterlee  W, Young  V M, Serpick  A. Empiric Therapy with carbenicillin and gentamycin for febrile patients with cancer and granulocytopenia.  N Engl J Med. 1971;;  284 1061-1065
    PubMedGoogle Scholar
  • 110 Schimpff  S C, Young  V, Greene  W, Vermeulen  G D, Moody  M R, Wiernik  P H. Origin of infection in acute nonlymphocytic leukemia: significance of hospital acquisition of potential pathogens.  Ann Intern Med. 1972;;  77 707-714
    PubMedGoogle Scholar
  • 111 Schimpff  S C, Scott  D A, Wade  J C. Infections in cancer patients: some controversial issues. Support Care Cancer 1994; 2: 94 - 104111a Schots R, Trullemans F, van Riet I, Kaufman L, Hafsia A, Meddeb B, Hadj Ali ZB, Ben Abid H, Lauwers S, van Camp B. The clinical impact of early gram-positive bacteremia and the use of vancomycin after allogenic bone marrow transplantation.  Transplantation. 2000;;  69 1511-1514
    PubMedGoogle Scholar
  • 112 Schuster  F, Graubner  U B, Schmid  I, Weiss  M, Belohradsky  B H. Vancomycin-resistant-enterococci - Colonisation of 24 Patients in a pediatric oncology unit.  Klin Pädiatr. 1998;;  210 261-263
    PubMedGoogle Scholar
  • 113 Schwalbe  R S, Stapleton  J T, Gilligan  P H. Emergence of Vancomycin Resistance in Coagulase-Negative Staphylococci. N Engl J Med 1987; 316: 927 - 931113a Schwarz C, Henrickson KJ, Roghmann K, Powell K. Prevention of Bacteremia Attributed to Luminal Colonization of Tunneled Central Venous Catheters With Vancomycin-Susceptible Organisms.  J Clin Oncol. 1990;;  8 1591-1597
    PubMedGoogle Scholar
  • 114 Serody  J S, Shea  T C. Prevention of infections in bone marrow transplant recipients.  Infect Dis Clin North Am. 1997;;  11 459-477
    CrossrefPubMedGoogle Scholar
  • 115 Shah  S S, Sinkowitz-Cochran  R L, Keyserling  H L, Jarvis  W R. Vancomycin use in pediatric neurosurgery patients.  Am J Infect Control. 1999;;  27 482-487
    PubMedGoogle Scholar
  • 116 Shay  D K, Goldmann  D A, Jarvis  W R. Reducing the Spread of Antimicrobial-Resistant Microorganisms: Control of Vancomycin-Resistant Enterococci.  Pediatr Clin North Am. 1995;;  42 703-716
    PubMedGoogle Scholar
  • 117 Shlaes  D M, Gerding  D N, John  J F, Vraig  W A, Bornstein  D L, Duncan  R A, Eckman  M R, Farrer  W E, Green  W H, Lorian  V, Levy  S, McGowan  J E, Paul  S M, Ruskin  J, Tenover  F C, Watanakunakorn  C. Society of Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Resistance in Hospitals.  Clin Infect Dis. 1997;;  25 584-599
    CrossrefPubMedGoogle Scholar
  • 118 Simon  A, Fleischhack  G, Hasan  C, Marklein  G, Bode  U. Clostridium-difficile-assoziierte Diarrhoe bei pädiatrischen Patienten - Vorkommen, Therapieindikationen und Behandlungsstrategie.  Hyg Med. 1998;;  23 109-114
    PubMedGoogle Scholar
  • 119 Simon  C, Stille  W. Antibiotika-Therapie in Klinik und Praxis. 10. Auflage. Schattauer Verlag, Stuttgart, New York; 1999:
    Google Scholar
  • 120 Sitges-Serra  A, Girvent  M. Catheter-related Bloodstream Infections.  World J Surg. 1999;;  23 589-595
    PubMedGoogle Scholar
  • 121 Schots  R, Trullemans  F, Van Riet  I, Kaufman  L, Hafsia  A, Meddeb  B, Hadj Ali  Z B, Ben Abid  H, Lauwers  S, Van Camp  B. The clinical impact of early gram-positive Bacteremia and the use of vancomycin after allogenic bone marrow transplantation.  Transplantation. 2000;;  69 1511-1514
    PubMedGoogle Scholar
  • 122 Schwartz  C, Henrickson  K J, Roghman  K, Powell  K. Prevention of Bacteremia attributed to luminal colonization of tunneled central venous catheters with Vancomycin-susceptible organisms.  J Clin Oncol. 1990;;  8 1591-1597
    PubMedGoogle Scholar
  • 123 Tauro  S, Dobie  D, Richardson  G, Hastings  M, Mahendra  P. Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.  Bone Marrow Transplant. 2000;;  26 1017-1019
    CrossrefPubMedGoogle Scholar
  • 124 Teinturier  C, Hartmann  O, Lemerle  J, Benhamou  E, Maraninchi  D. Prevention of gram-positive infections in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized controlled trial of vancomycin.  Pediatr Hematol Oncol. 1995;;  12 73-77
    PubMedGoogle Scholar
  • 125 Van der Ven  A J, Koopmans  P P, Vree  T B, van der Meer  J W. Adverse reactions to co-trimoxazole in HIV infection.  Lancet. 1991;;  338 431-433
    CrossrefPubMedGoogle Scholar
  • 126 Van der Waaij  D, Berghuis  D JM, Lekkerkerk  J EC. Colonisation resistance in the digestive tract in mice during systemic antibiotic treatment.  J Hyg (Lond). 1972;;  70 605
    PubMedGoogle Scholar
  • 127 Verhoef  J, Rozenberg-Arska  M, Dekker  A. Prevention of Infection in the Neutropenic Patient.  Rev Infect Dis. 1989;;  11 Suppl 7 S1545-S1550
    PubMedGoogle Scholar
  • 128 Viot  M, Klastersky  J. Prophylaxis and empiric therapy for streptococcal infections in febrile neutropenic patients.  Eur J Cancer. 1991;;  27 818-819
    PubMedGoogle Scholar
  • 129 Vollard  E J, Clasener  H A. Colonisation resistance.  Antimicrob Agents Chemother. 1994;;  38 409-414
    PubMedGoogle Scholar
  • 130 Ward  M S, Lam  K V, Cannell  P K, Herrmann  R P. Mycobacterial central venous catheter tunnel infection: a difficult problem.  Bone Marrow Transplantation. 1999;;  24 325-329
    CrossrefPubMedGoogle Scholar
  • 131 Wehl  G, Allerberger  F, Heitger  A, Meister  B, Mauerer  K, Fink  F M. Trends in infection morbidity in a pediatric oncology ward, 1986 - 1995.  Med Pediatr Oncol. 1999;;  32 336-342
    CrossrefPubMedGoogle Scholar
  • 132 Weinstein  M R, Dedier  H, Brunton  J, Campbell  I, Conly  J M. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium.  Clin Infect Dis. 1999;;  29 361-366
    PubMedGoogle Scholar
  • 133 Wilson  J M, Guiney  D G. Failure of Oral Trimethoprim-Sulfamethoxazole Prophylaxis in Acute Leukemia.  N Engl J Med. 1982;;  306 16-20
    PubMedGoogle Scholar
  • 134 Winston  D J, Ho  W G, Nakao  S L, Gale  R P, Champlin  R E. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.  Am J Med. 1986;;  80 884-890
    CrossrefPubMedGoogle Scholar
  • 135 Winston  D J, Ho  W G, Bruckner  D A, Gale  R P, Champlin  R E. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.  Am J Med. 1990;;  88 36-42
    CrossrefPubMedGoogle Scholar
  • 136 Winston  D J, Emmanouilides  C, Kroeber  A, Hindler  J, Bruckner  D A, Territo  M C, Busuttil  R W. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.  Clin Infect Dis. 2000;;  30 790-797
    CrossrefPubMedGoogle Scholar
  • 137 Zinner  S H. Changing Epidemiology of Infections in Patients with Neutropenia and Cancer: Emphasis on Gram-Positive and Resistant Bacteria.  Clin Infect Dis. 1999;;  29 490-494
    PubMedGoogle Scholar

Dr. med. Arne Simon

Abteilung für pädiatrische Hämatologie und Onkologie
Zentrum für Kinderheilkunde

Adenauerallee 119

53113 Bonn

Phone: 02 28/2 87 32 54

Fax: 02 28/2 87 33 01

Email: Dr.med.A.Simon@t-online.de

      >